Primary myelofibrosis

Changed by Mostafa Elfeky, 17 May 2017

Updates to Article Attributes

Body was changed:

Myelofibrosis is a haematological disorder where there is the replacement of bone marrow with collagenous connective tissue and progressive fibrosis. It is also classified as a myeloproliferative disorder. It is characterised by:

Epidemiology

It usually affects the middle-aged to elderly (mean age 60 years6). The estimated prevalence is at ~1:100,000.

Pathology

Non-neoplastic fibroblasts produce collagen, which replaces normal bone marrow elements. This bone marrow fibrosis is a result of an inappropriate release of PDGF and TGF-ß from neoplastic megakaryocytes 8.

Subtypes

It can be broadly classified into:

Radiographic features

Most radiological features are a result of EMH and seen in many systems.

General
Musculoskeletal
  • osteosclerosis
    • tends to be diffuse and there is a lack of architectural distortion
    • frequent sites include
      • axial skeleton
      • ribs
      • proximal humerus and femur
    • bone scan may give "superscan" appearance
Abdominal
Cardiovascular
  • may show evidence of congestive cardiac failure due to anaemia 3

Treatment and prognosis

Prognosis is poor, with slow progression and death usually within 2-3 years. It can also transform into acute myeloid leukaemia (AML) in a small number of patients 10.

Complications

Differential diagnosis

General differential considerations include:

  • -<li>for musculoskeletal manifestations: consider the <a href="/articles/diffuse-bony-sclerosis-differential-diagnosis">differential diagnosis of diffuse bony sclerosis</a>
  • +<li>for musculoskeletal manifestations: consider the <a href="/articles/diffuse-bone-sclerosis-differential">differential diagnosis of diffuse bony sclerosis</a>
Images Changes:

Image 8 CT (C+ portal venous phase) ( create )

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.